JP2021502829A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502829A5 JP2021502829A5 JP2020544387A JP2020544387A JP2021502829A5 JP 2021502829 A5 JP2021502829 A5 JP 2021502829A5 JP 2020544387 A JP2020544387 A JP 2020544387A JP 2020544387 A JP2020544387 A JP 2020544387A JP 2021502829 A5 JP2021502829 A5 JP 2021502829A5
- Authority
- JP
- Japan
- Prior art keywords
- promoter
- antigen
- item
- cells
- immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims description 75
- 239000000427 antigen Substances 0.000 claims description 65
- 108091007433 antigens Proteins 0.000 claims description 65
- 102000036639 antigens Human genes 0.000 claims description 65
- 206010028980 Neoplasm Diseases 0.000 claims description 43
- 102000005962 receptors Human genes 0.000 claims description 27
- 108020003175 receptors Proteins 0.000 claims description 27
- 150000007523 nucleic acids Chemical group 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 19
- 239000008194 pharmaceutical composition Substances 0.000 claims description 18
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 16
- 208000035269 cancer or benign tumor Diseases 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 244000052769 pathogen Species 0.000 claims description 9
- 230000001717 pathogenic effect Effects 0.000 claims description 9
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 8
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 8
- 230000014509 gene expression Effects 0.000 claims description 7
- 230000004044 response Effects 0.000 claims description 7
- 108090000695 Cytokines Proteins 0.000 claims description 6
- 102000004127 Cytokines Human genes 0.000 claims description 6
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims description 6
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 6
- 230000016396 cytokine production Effects 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 230000004083 survival effect Effects 0.000 claims description 6
- 208000004736 B-Cell Leukemia Diseases 0.000 claims description 5
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 5
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 5
- 208000034578 Multiple myelomas Diseases 0.000 claims description 5
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 5
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 5
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims description 5
- 201000005787 hematologic cancer Diseases 0.000 claims description 5
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims description 5
- 230000003308 immunostimulating effect Effects 0.000 claims description 5
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims description 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 4
- 102100037850 Interferon gamma Human genes 0.000 claims description 4
- 108010074328 Interferon-gamma Proteins 0.000 claims description 4
- 102000003814 Interleukin-10 Human genes 0.000 claims description 4
- 108090000174 Interleukin-10 Proteins 0.000 claims description 4
- 108010002350 Interleukin-2 Proteins 0.000 claims description 4
- 102100023123 Mucin-16 Human genes 0.000 claims description 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 4
- 108091008874 T cell receptors Proteins 0.000 claims description 4
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 230000000259 anti-tumor effect Effects 0.000 claims description 4
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 208000003747 lymphoid leukemia Diseases 0.000 claims description 4
- 102000001301 EGF receptor Human genes 0.000 claims description 3
- -1 EGP-40 Proteins 0.000 claims description 3
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 claims description 3
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims description 3
- 108091027981 Response element Proteins 0.000 claims description 3
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 3
- 230000001605 fetal effect Effects 0.000 claims description 3
- 230000028993 immune response Effects 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 230000001177 retroviral effect Effects 0.000 claims description 3
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims description 2
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 2
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 claims description 2
- 108010085238 Actins Proteins 0.000 claims description 2
- 102100026402 Adhesion G protein-coupled receptor E2 Human genes 0.000 claims description 2
- 101100279855 Arabidopsis thaliana EPFL5 gene Proteins 0.000 claims description 2
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims description 2
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims description 2
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 2
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims description 2
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims description 2
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims description 2
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims description 2
- 102100032912 CD44 antigen Human genes 0.000 claims description 2
- 102100025221 CD70 antigen Human genes 0.000 claims description 2
- 102000024905 CD99 Human genes 0.000 claims description 2
- 108060001253 CD99 Proteins 0.000 claims description 2
- 101150031358 COLEC10 gene Proteins 0.000 claims description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 2
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims description 2
- 108010009685 Cholinergic Receptors Proteins 0.000 claims description 2
- 101100118093 Drosophila melanogaster eEF1alpha2 gene Proteins 0.000 claims description 2
- 108010055196 EphA2 Receptor Proteins 0.000 claims description 2
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 claims description 2
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims description 2
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims description 2
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 2
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 2
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 2
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 claims description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 2
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 2
- 101000718211 Homo sapiens Adhesion G protein-coupled receptor E2 Proteins 0.000 claims description 2
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 2
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims description 2
- 101100496086 Homo sapiens CLEC12A gene Proteins 0.000 claims description 2
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims description 2
- 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 claims description 2
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims description 2
- 101000920667 Homo sapiens Epithelial cell adhesion molecule Proteins 0.000 claims description 2
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 2
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 claims description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 2
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims description 2
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 claims description 2
- 101001078143 Homo sapiens Integrin alpha-IIb Proteins 0.000 claims description 2
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims description 2
- 101000984189 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 2 Proteins 0.000 claims description 2
- 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims description 2
- 101001005719 Homo sapiens Melanoma-associated antigen 3 Proteins 0.000 claims description 2
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims description 2
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 2
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims description 2
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims description 2
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims description 2
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 claims description 2
- 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 claims description 2
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims description 2
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims description 2
- 101001094545 Homo sapiens Retrotransposon-like protein 1 Proteins 0.000 claims description 2
- 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 claims description 2
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims description 2
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 2
- 101000621309 Homo sapiens Wilms tumor protein Proteins 0.000 claims description 2
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims description 2
- 102100032816 Integrin alpha-6 Human genes 0.000 claims description 2
- 102100025306 Integrin alpha-IIb Human genes 0.000 claims description 2
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims description 2
- 102100025583 Leukocyte immunoglobulin-like receptor subfamily B member 2 Human genes 0.000 claims description 2
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims description 2
- 102100025082 Melanoma-associated antigen 3 Human genes 0.000 claims description 2
- 108090000015 Mesothelin Proteins 0.000 claims description 2
- 102000003735 Mesothelin Human genes 0.000 claims description 2
- 102100034256 Mucin-1 Human genes 0.000 claims description 2
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims description 2
- 102000003729 Neprilysin Human genes 0.000 claims description 2
- 108090000028 Neprilysin Proteins 0.000 claims description 2
- 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 claims description 2
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims description 2
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims description 2
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 claims description 2
- 102000036673 PRAME Human genes 0.000 claims description 2
- 108060006580 PRAME Proteins 0.000 claims description 2
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 claims description 2
- 102100040120 Prominin-1 Human genes 0.000 claims description 2
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims description 2
- 101000737809 Rattus norvegicus Cadherin-related family member 5 Proteins 0.000 claims description 2
- 108010002687 Survivin Proteins 0.000 claims description 2
- 102100035721 Syndecan-1 Human genes 0.000 claims description 2
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims description 2
- 239000004098 Tetracycline Substances 0.000 claims description 2
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 2
- 102100039094 Tyrosinase Human genes 0.000 claims description 2
- 108060008724 Tyrosinase Proteins 0.000 claims description 2
- 102100022748 Wilms tumor protein Human genes 0.000 claims description 2
- 102000034337 acetylcholine receptors Human genes 0.000 claims description 2
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 2
- 229940011871 estrogen Drugs 0.000 claims description 2
- 239000000262 estrogen Substances 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 239000003446 ligand Substances 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 210000000581 natural killer T-cell Anatomy 0.000 claims description 2
- 210000001672 ovary Anatomy 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 210000003289 regulatory T cell Anatomy 0.000 claims description 2
- 101150047061 tag-72 gene Proteins 0.000 claims description 2
- 229960002180 tetracycline Drugs 0.000 claims description 2
- 229930101283 tetracycline Natural products 0.000 claims description 2
- 235000019364 tetracycline Nutrition 0.000 claims description 2
- 150000003522 tetracyclines Chemical class 0.000 claims description 2
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 230000003750 conditioning effect Effects 0.000 claims 1
- 230000000139 costimulatory effect Effects 0.000 claims 1
- 230000005965 immune activity Effects 0.000 claims 1
- 230000004068 intracellular signaling Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 210000004324 lymphatic system Anatomy 0.000 claims 1
- 230000002611 ovarian Effects 0.000 claims 1
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 1
- 230000019491 signal transduction Effects 0.000 claims 1
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 description 6
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 3
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762585879P | 2017-11-14 | 2017-11-14 | |
| US62/585,879 | 2017-11-14 | ||
| PCT/US2018/061003 WO2019099483A1 (en) | 2017-11-14 | 2018-11-14 | Il-36 secreting immunoresponsive cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502829A JP2021502829A (ja) | 2021-02-04 |
| JP2021502829A5 true JP2021502829A5 (enExample) | 2021-12-23 |
Family
ID=66538783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544387A Pending JP2021502829A (ja) | 2017-11-14 | 2018-11-14 | Ｉｌ−３６を分泌する免疫応答性細胞およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11766474B2 (enExample) |
| EP (1) | EP3710020A4 (enExample) |
| JP (1) | JP2021502829A (enExample) |
| CN (1) | CN111655270A (enExample) |
| AU (2) | AU2018367452B2 (enExample) |
| CA (1) | CA3082570A1 (enExample) |
| WO (1) | WO2019099483A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019099483A1 (en) * | 2017-11-14 | 2019-05-23 | Memorial Sloan-Kettering Cancer Center | Il-36 secreting immunoresponsive cells and uses thereof |
| US20230000913A1 (en) * | 2019-08-13 | 2023-01-05 | King's College London | Immunoresponsive cells armoured with spatiotemporally restricted activity of cytokines of the il-1 superfamily |
| WO2021055731A1 (en) * | 2019-09-20 | 2021-03-25 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Il-36 cytokine expressing oncolytic viruses for treating cancer |
| KR20210058038A (ko) | 2019-11-13 | 2021-05-24 | (주)아모레퍼시픽 | 인터루킨-36 감마를 포함하는 피부 미백용 조성물 |
| CN115701999A (zh) * | 2020-07-09 | 2023-02-14 | 南京传奇生物科技有限公司 | 用白介素-36工程化γδT细胞用于免疫疗法 |
| CN116077625A (zh) * | 2020-11-16 | 2023-05-09 | 桂林医学院附属医院 | 小鼠截短IL-36γ蛋白在制备免疫调节药物中的应用 |
| JP2023553861A (ja) | 2020-12-02 | 2023-12-26 | 上海復宏漢霖生物技術股▲フン▼有限公司 | 抗ＧＡＲＰ／ＴＧＦβ抗体及び使用方法 |
| MX2024002436A (es) * | 2021-08-24 | 2024-06-03 | Ecole Polytechnique Fed Lausanne Epfl | Celulas que expresan il-10 para inmunoterapias mejoradas contra el cancer. |
| CA3240585A1 (en) | 2021-12-17 | 2023-06-22 | Wenfeng Xu | Anti-ox40 antibodies, multispecific antibodies and methods of use |
| EP4448579A4 (en) | 2021-12-17 | 2026-02-18 | Shanghai Henlius Biotech Inc | ANTI-OX40 ANTIBODIES AND METHODS OF USE |
| EP4499708A1 (en) | 2022-03-25 | 2025-02-05 | Shanghai Henlius Biotech, Inc. | Anti-msln antibodies and methods of use |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| JPS6412935A (en) | 1987-07-02 | 1989-01-17 | Mitsubishi Electric Corp | Constant-speed travel device for vehicle |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US7446190B2 (en) | 2002-05-28 | 2008-11-04 | Sloan-Kettering Institute For Cancer Research | Nucleic acids encoding chimeric T cell receptors |
| US20130071414A1 (en) | 2011-04-27 | 2013-03-21 | Gianpietro Dotti | Engineered cd19-specific t lymphocytes that coexpress il-15 and an inducible caspase-9 based suicide gene for the treatment of b-cell malignancies |
| CN112458057A (zh) * | 2012-10-02 | 2021-03-09 | 纪念斯隆-凯特琳癌症中心 | 用于免疫疗法的组合物和方法 |
| EP2961831B1 (en) * | 2013-02-26 | 2020-06-10 | Memorial Sloan Kettering Cancer Center | Compositions and methods for immunotherapy |
| EP2997134B1 (en) * | 2013-05-14 | 2020-06-24 | Board of Regents, The University of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| SI3888674T1 (sl) * | 2014-04-07 | 2024-08-30 | Novartis Ag | Zdravljenje raka z uporabo antigenskega himernega receptorja proti-CD19 |
| CN112877291A (zh) * | 2014-04-10 | 2021-06-01 | 西雅图儿童医院 (Dba西雅图儿童研究所) | 基因修饰的t细胞产品、其制备方法和用途 |
| PT3227339T (pt) * | 2014-12-05 | 2022-01-14 | Eureka Therapeutics Inc | Recetores de antigénio quiméricos que têm como alvo o recetor 4 acoplado a proteína g e utilizações dos mesmos |
| EP4310097A3 (en) * | 2014-12-05 | 2024-04-03 | Memorial Sloan Kettering Cancer Center | Chimeric antigen receptors targeting b-cell maturation antigen and uses thereof |
| WO2017075537A1 (en) * | 2015-10-30 | 2017-05-04 | Aleta Biotherapeutics Inc. | Compositions and methods for treatment of cancer |
| HRP20221135T8 (hr) * | 2016-05-18 | 2023-02-03 | Modernatx, Inc. | KOMBINACIJE mRNK KOJE KODIRAJU IMUNOMODULIRAJUĆE POLIPEPTIDE I NJIHOVE UPOTREBE |
| WO2019099483A1 (en) * | 2017-11-14 | 2019-05-23 | Memorial Sloan-Kettering Cancer Center | Il-36 secreting immunoresponsive cells and uses thereof |
-
2018
- 2018-11-14 WO PCT/US2018/061003 patent/WO2019099483A1/en not_active Ceased
- 2018-11-14 CA CA3082570A patent/CA3082570A1/en active Pending
- 2018-11-14 CN CN201880086462.6A patent/CN111655270A/zh active Pending
- 2018-11-14 JP JP2020544387A patent/JP2021502829A/ja active Pending
- 2018-11-14 AU AU2018367452A patent/AU2018367452B2/en active Active
- 2018-11-14 EP EP18878826.9A patent/EP3710020A4/en active Pending
-
2020
- 2020-05-13 US US15/930,966 patent/US11766474B2/en active Active
-
2023
- 2023-08-10 US US18/447,439 patent/US12544440B2/en active Active
-
2024
- 2024-09-10 AU AU2024219547A patent/AU2024219547A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502829A5 (enExample) | ||
| JP2021502828A5 (enExample) | ||
| IL314563A (en) | Non-HLA-restricted T-cell receptors and their uses | |
| US20240059754A1 (en) | Chimeric antigen receptors and enhancement of anti-tumor activity | |
| KR101890638B1 (ko) | Car 발현 벡터 및 car 발현 t 세포 | |
| JPWO2019157454A5 (enExample) | ||
| JP2016508728A5 (enExample) | ||
| CN109689694B (zh) | 与其受体IL-2Rβ结合的IL2作为用来增强自然杀伤细胞和调节性T细胞活性的平台 | |
| JP2017523784A5 (enExample) | ||
| JPWO2020088631A5 (enExample) | ||
| CA2425862A1 (en) | Cd19-specific redirected immune cells | |
| EP3394105B1 (en) | Chimeric antigen receptor with cytokine receptor activating or blocking domain | |
| US20210379149A1 (en) | Increasing or Maintaining T-Cell Subpopulations in Adoptive T-Cell Therapy | |
| KR20180021683A (ko) | 생체내 지속성 및 치료학적 활성 및 이의 증식을 위한 nkt-세포 서브세트 | |
| Zhang et al. | Genetic engineering with T cell receptors | |
| US20230398216A1 (en) | Chimeric activation receptors | |
| JPWO2021071962A5 (enExample) | ||
| AU2023279726A1 (en) | Compositions and methods comprising chimeric adaptor polypeptides | |
| Heiblig et al. | Adoptive immunotherapy for acute leukemia: new insights in chimeric antigen receptors | |
| TW202309269A (zh) | 重組抗原呈現細胞 | |
| Roeven et al. | Immunotherapeutic approaches to treat multiple myeloma | |
| Chekmasova et al. | Adoptive T cell immunotherapy strategies for the treatment of patients with ovarian cancer | |
| JPWO2022098925A5 (enExample) | ||
| Riedle et al. | In vivo activation and expansion of T cells by a bi‐specific antibody abolishes metastasis formation of human melanoma cells in SCID mice | |
| Chaux et al. | T‐cell co‐stimulation by the CD28 ligand B7 is involved in the immune response leading to rejection of a spontaneously regressive tumor |